JP2013532132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532132A5 JP2013532132A5 JP2013510716A JP2013510716A JP2013532132A5 JP 2013532132 A5 JP2013532132 A5 JP 2013532132A5 JP 2013510716 A JP2013510716 A JP 2013510716A JP 2013510716 A JP2013510716 A JP 2013510716A JP 2013532132 A5 JP2013532132 A5 JP 2013532132A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- branched
- saturated
- linear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 20
- 229920006395 saturated elastomer Polymers 0.000 claims 10
- 238000000034 method Methods 0.000 claims 6
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims 5
- 125000000524 functional group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 3
- 108091005804 Peptidases Proteins 0.000 claims 3
- 125000006575 electron-withdrawing group Chemical group 0.000 claims 3
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- -1 antibodies Proteins 0.000 claims 2
- ZPWOOKQUDFIEIX-UHFFFAOYSA-N cyclooctyne Chemical compound C1CCCC#CCC1 ZPWOOKQUDFIEIX-UHFFFAOYSA-N 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 235000019833 protease Nutrition 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000005741 Metalloproteases Human genes 0.000 claims 1
- 108010006035 Metalloproteases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 125000001743 benzylic group Chemical group 0.000 claims 1
- 229920001222 biopolymer Polymers 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000001143 conditioned effect Effects 0.000 claims 1
- 239000000412 dendrimer Substances 0.000 claims 1
- 229920000736 dendritic polymer Polymers 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
- 125000003147 glycosyl group Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920000768 polyamine Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 235000019419 proteases Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1053921 | 2010-05-20 | ||
| FR1053921A FR2960153B1 (fr) | 2010-05-20 | 2010-05-20 | Nouveaux bras autoreactifs et prodrogues les comprenant |
| PCT/IB2011/052184 WO2011145068A1 (fr) | 2010-05-20 | 2011-05-18 | Nouveaux bras autoréactifs et prodrogues les comprenant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532132A JP2013532132A (ja) | 2013-08-15 |
| JP2013532132A5 true JP2013532132A5 (enExample) | 2014-06-26 |
| JP6223824B2 JP6223824B2 (ja) | 2017-11-01 |
Family
ID=43063203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510716A Active JP6223824B2 (ja) | 2010-05-20 | 2011-05-18 | 新規な自己反応性アーム及び同物を含むプロドラッグ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9000135B2 (enExample) |
| EP (1) | EP2571528B1 (enExample) |
| JP (1) | JP6223824B2 (enExample) |
| CA (1) | CA2799773C (enExample) |
| ES (1) | ES2666562T3 (enExample) |
| FR (1) | FR2960153B1 (enExample) |
| WO (1) | WO2011145068A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3017298B1 (fr) * | 2014-02-07 | 2016-03-04 | Centre Nat Rech Scient | Conjugues et pro-drogues pour le traitement du cancer et de maladies inflammatoires |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| ES2785551T3 (es) | 2014-06-30 | 2020-10-07 | Glykos Finland Oy | Derivado de sacárido de una carga útil tóxica y sus conjugados con anticuerpos |
| WO2016144814A1 (en) * | 2015-03-06 | 2016-09-15 | Colorado State University Research Foundation | Synthesis and utility of new capgroup largazole analogs |
| KR102368068B1 (ko) | 2015-08-24 | 2022-02-25 | 삼성전자주식회사 | 반도체 소자 제조용 조성물 및 이를 이용하는 반도체 소자의 제조 방법 |
| CA3006249A1 (en) * | 2015-11-25 | 2017-06-01 | Legochem Biosciences, Inc. | Antibody-drug conjugates comprising branched linkers and methods related thereto |
| WO2017089894A1 (en) | 2015-11-25 | 2017-06-01 | Legochem Biosciences, Inc. | Conjugates comprising peptide groups and methods related thereto |
| HRP20240795T1 (hr) | 2015-11-25 | 2024-09-13 | Ligachem Biosciences Inc. | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima |
| KR102085798B1 (ko) | 2016-12-28 | 2020-03-06 | 주식회사 인투셀 | 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물 |
| IL269535B2 (en) | 2017-03-29 | 2024-11-01 | Ligachem Biosciences Inc | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
| EP3624854A1 (en) | 2017-05-16 | 2020-03-25 | Université de Strasbourg | Protein-drug conjugates and their use in the treatment of cancers |
| HUE068574T2 (hu) * | 2018-04-03 | 2025-01-28 | Syndivia | Citotoxikus hatóanyag konjugátuma és az említett konjugátum prodrugja |
| EP3790591A4 (en) | 2018-05-09 | 2022-05-11 | LegoChem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| KR102258299B1 (ko) * | 2019-03-21 | 2021-05-28 | 고려대학교 산학협력단 | 대장암 선택적 항암 치료진단제 |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| WO2022140144A1 (en) | 2020-12-21 | 2022-06-30 | Colorado State University Research Foundation | Synthesis of structural analogs of largazole and associated compounds |
| WO2022150721A1 (en) * | 2021-01-08 | 2022-07-14 | Lycia Therapeutics, Inc. | Bifunctional folate receptor binding compounds |
| AU2022248565A1 (en) | 2021-03-30 | 2023-10-05 | Centre National De La Recherche Scientifique - Cnrs - | Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties |
| CN117957020A (zh) | 2021-07-14 | 2024-04-30 | 利西亚治疗公司 | Asgpr细胞表面受体结合化合物和缀合物 |
| FR3126982B1 (fr) | 2021-09-14 | 2023-09-15 | Centre Nat Rech Scient | Vecteurs ciblant la beta-d-n-acetylglucosaminidase |
| WO2024238912A1 (en) * | 2023-05-17 | 2024-11-21 | OncoC4, Inc. | Ph-sensitive anti-ctla-4 antibodies and uses thereof |
| EP4534101A1 (en) | 2023-10-02 | 2025-04-09 | Eli Lilly and Company | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1981001145A1 (en) | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
| US4379166A (en) * | 1981-08-03 | 1983-04-05 | Schering Corporation | Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols |
| AT399874B (de) * | 1990-06-05 | 1995-08-25 | Glaxo Group Ltd | Dichloranilinverbindung |
| FR2676058B1 (fr) * | 1991-04-30 | 1994-02-25 | Hoechst Lab | Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers. |
| EP0647450A1 (en) * | 1993-09-09 | 1995-04-12 | BEHRINGWERKE Aktiengesellschaft | Improved prodrugs for enzyme mediated activation |
| EP1880737A1 (fr) * | 1994-08-19 | 2008-01-23 | La Region Wallonne | Composés, composition pharmaceutique et dispositif de diagnostic les comprenant et leur utilisation |
| FR2852606A1 (fr) * | 2003-03-18 | 2004-09-24 | Inst Nat Sante Rech Med | Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie |
| WO2005115105A2 (en) * | 2004-05-10 | 2005-12-08 | Northwestern University | Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase |
| EP2098533A1 (en) | 2008-03-07 | 2009-09-09 | Pharmachemie B.V. | Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
-
2010
- 2010-05-20 FR FR1053921A patent/FR2960153B1/fr not_active Expired - Fee Related
-
2011
- 2011-05-18 ES ES11724800.5T patent/ES2666562T3/es active Active
- 2011-05-18 CA CA2799773A patent/CA2799773C/fr active Active
- 2011-05-18 WO PCT/IB2011/052184 patent/WO2011145068A1/fr not_active Ceased
- 2011-05-18 JP JP2013510716A patent/JP6223824B2/ja active Active
- 2011-05-18 EP EP11724800.5A patent/EP2571528B1/fr active Active
- 2011-05-18 US US13/699,173 patent/US9000135B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532132A5 (enExample) | ||
| JP2015508074A5 (enExample) | ||
| CN115778904B (zh) | 一种用于体外转染和体内递送mRNA的制剂 | |
| CN115197080A (zh) | 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用 | |
| JP2014516991A5 (enExample) | ||
| JP2011057686A5 (enExample) | ||
| JP2012521358A5 (enExample) | ||
| JP2014515406A5 (enExample) | ||
| HRP20170433T1 (hr) | Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci | |
| JP2017530109A5 (ja) | 前立腺癌についてのｐｓｍａを標的とした放射性核種治療中の臓器の保護のための組成物及びキット | |
| HRP20190878T1 (hr) | Modificirane aminokiseline koje sadrže azidnu grupu | |
| AU2009249403A1 (en) | Methods and compositions comprising novel cationic lipids | |
| RU2015119557A (ru) | Конъюгаты лекарственное вещество-белок | |
| RU2013128361A (ru) | Her2-связывающие белки, меченые комплексом 18f-фторида алюминия и nota | |
| JP2016535058A5 (enExample) | ||
| JP2012521201A5 (enExample) | ||
| US20250288531A1 (en) | Amino acid-based cationic lipid containing unsaturated bonds | |
| CN104274830A (zh) | 一种基于抗原共价结合壳聚糖纳米粒的鼻腔免疫载体 | |
| JP2014515758A5 (enExample) | ||
| JP2018507689A5 (enExample) | ||
| JP2001515060A (ja) | 新リポポリアミン、その調製および適用 | |
| JP2001515060A5 (enExample) | ||
| M. Ziora et al. | Lipoamino acids as major components of absorption promoters in drug delivery | |
| JP2010540488A5 (enExample) | ||
| KR20140141229A (ko) | 점막 점착성 폴리감마글루탐산 나노마이셀 및 이를 이용한 약물 전달체 |